Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy

Fig. 2

A ROC analysis showed moderately high accuracy levels for discrimination of aMCI from control in the Nijmegen aMCI patients and controls (gray line) and the Barcelona aMCI patients and controls. B ROC analysis showed consistently high accuracy levels for discrimination of AD from control in the Nijmegen AD patients and controls (gray line) and the Barcelona AD patients and controls. Abbreviations: AD, Alzheimer’s disease; AUC area under the curve. The Barcelona cohort serves as a validation cohort

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193